Quarterly report pursuant to Section 13 or 15(d)

Equity (Tables)

v3.24.2.u1
Equity (Tables)
3 Months Ended
Jun. 30, 2023
Equity  
Summary of stock-based compensation expense by statement of operations line item

The following table summarizes, by Condensed Consolidated Statements of Operations line item, stock-based compensation expense (in thousands):

Three Months Ended

June 30,

    

2023

    

2022

 

Cost of goods sold

$

15

    

$

3

Research and development

 

26

 

25

Selling, general and administrative

 

265

 

204

Stock-based compensation expense

$

306

$

232

Summary of restricted stock unit and performance restricted stock unit ("PRSU") activity

Weighted

Average Grant

Date Fair

Restricted Stock Units and Performance Restricted Stock Units

Shares

Value

 

Non-vested restricted stock units outstanding at March 31, 2023

    

842,631

    

$

3.13

Granted

 

679,060

0.77

Vested and issued

 

(39,923)

5.10

Forfeited

 

(4,237)

3.90

Non-vested restricted stock units outstanding at June 30, 2023

 

1,477,531

1.99

Restricted stock units expected to vest beyond June 30, 2023(1)

 

1,477,531

$

1.99

(1) Unvested RSUs expected to vest beyond the Effective Date were cancelled on the Effective Date in accordance with the Plan. See Note 17–Subsequent Events in the Notes to Condensed Consolidated Financial Statements for further discussion of the Company’s emergence from bankruptcy.
Summary of additional information on restricted stock units and performance restricted stock units

Three Months Ended June 30,

    

2023

    

2022

Restricted stock compensation expense (in thousands)

    

$

306

    

$

232

Aggregate fair value of restricted stock units vested and issued (in thousands)

    

$

48

    

$

129

Weighted average grant date fair value of restricted stock units granted during the period

    

$

1.20

    

$

2.44